ClostraBio Gains INVENT Illinois Investment, Appoints New CSO, Announces Plans for First Product Launch in Summer 2025
For the fourth quarter of 2024 company reached 0 of $0.00 per share compare to $0.00 a year prior and from $0.00 per share from the prior reporting season. The revenue remained unaffected to $0.00 million from $0.18 million in the similar reporting season a year prior and sequentially from $2.85 million. “As ClostraBio prepares…